Curaleaf Holdings CURLF
OTC CURLF
$9.99 +0.39 (+4.06%)
As of: Aug 21, 2026 · 3:59 PM EDT

Curaleaf Holdings (CURLF) Beginning Cash Balance (2020 - 2023)

Curaleaf Holdings (CURLF) posted quarterly Beginning Cash Balance of $73.5 million for Q1 2021, up 73.82% year-over-year from $42.3 million in Q1 2020, and up 73.82% quarter-over-quarter from $42.3 million in Q1 2020.

Curaleaf Holdings (CURLF) Beginning Cash Balance (2020 - 2023) Analysis & Trends

Curaleaf Holdings' Beginning Cash Balance history runs 2 years deep, the most recent figure standing at $73.5 million for Q1 2021.

  • In Q1 2021, Beginning Cash Balance rose 73.82% year-over-year to $73.5 million; the TTM figure through Dec 2021 stood at $73.5 million (up 73.82% YoY), while the FY2021 annual figure was $73.5 million, up 73.82% from the prior year.
  • Beginning Cash Balance for Q1 2021 stood at $73.5 million, up from $42.3 million in the prior quarter.
  • The five-year high for Beginning Cash Balance was $73.5 million in Q1 2021, with the low at $42.3 million in Q1 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 44.51 Bn 43.55 Bn -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn -
10 Curaleaf Holdings 2.61 Bn 2.52 Bn 169.91 Mn

Historic Data

Download Data
DateValue
Jun 30, 2023 163.18 Mn
Jun 30, 2023 163.18 Mn
Sep 30, 2022 299.33 Mn
Sep 30, 2022 299.33 Mn
Jun 30, 2022 299.33 Mn
Jun 30, 2022 299.33 Mn
Dec 31, 2021 73.54 Mn
Dec 31, 2021 73.54 Mn
Sep 30, 2021 73.54 Mn
Sep 30, 2021 73.54 Mn
Jun 30, 2021 73.54 Mn
Jun 30, 2021 73.54 Mn
Mar 31, 2021 73.54 Mn
Mar 31, 2021 73.54 Mn
Mar 31, 2020 42.31 Mn
Mar 31, 2020 42.31 Mn